Envestnet Asset Management
CBAY

Envestnet Asset Management’s Cymabay Therapeutics CBAY Stock Holding History

Envestnet Asset Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-39,544
Closed -$934K – 4319
2023
Q4 		$934K Sell
39,544
-23,884
-38% -$425K ﹤0.01% 2981
2023
Q3 		$946K Buy
+63,428
New +$841K ﹤0.01% 2847

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Envestnet Asset Management's CBAY Position: Q1 2024 in Review

Envestnet Asset Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 39,544 shares — an estimated $934K sold.

Envestnet Asset Management first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $946K in Q3 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Envestnet Asset Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Envestnet Asset Management sold 39,544 Cymabay Therapeutics shares in Q1 2024, an estimated $934K.
  • Envestnet Asset Management first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
  • Envestnet Asset Management's Cymabay Therapeutics position peaked at $946K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Envestnet Asset Management's 13F filing for Q1 2024, filed 13 May 2024.